Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels

Radiation esophagitis (RE) is a common adverse event associated with radiotherapy for non–small cell lung cancer (NSCLC). While plasma cytokine levels have been correlated with other forms of radiation-induced toxicity, their association with RE has been less well studied. We analyzed data from 126...

Full description

Bibliographic Details
Main Authors: Peter G. Hawkins, Philip S. Boonstra, Stephen T. Hobson, James A. Hayman, Randall K. Ten Haken, Martha M. Matuszak, Paul Stanton, Gregory P. Kalemkerian, Theodore S. Lawrence, Matthew J. Schipper, Feng-Ming (Spring) Kong, Shruti Jolly
Format: Article
Language:English
Published: Elsevier 2018-02-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523317303534
_version_ 1818128240447848448
author Peter G. Hawkins
Philip S. Boonstra
Stephen T. Hobson
James A. Hayman
Randall K. Ten Haken
Martha M. Matuszak
Paul Stanton
Gregory P. Kalemkerian
Theodore S. Lawrence
Matthew J. Schipper
Feng-Ming (Spring) Kong
Shruti Jolly
author_facet Peter G. Hawkins
Philip S. Boonstra
Stephen T. Hobson
James A. Hayman
Randall K. Ten Haken
Martha M. Matuszak
Paul Stanton
Gregory P. Kalemkerian
Theodore S. Lawrence
Matthew J. Schipper
Feng-Ming (Spring) Kong
Shruti Jolly
author_sort Peter G. Hawkins
collection DOAJ
description Radiation esophagitis (RE) is a common adverse event associated with radiotherapy for non–small cell lung cancer (NSCLC). While plasma cytokine levels have been correlated with other forms of radiation-induced toxicity, their association with RE has been less well studied. We analyzed data from 126 patients treated on 4 prospective clinical trials. Logistic regression models based on combinations of dosimetric factors [maximum dose to 2 cubic cm (D2cc) and generalized equivalent uniform dose (gEUD)], clinical variables, and pretreatment plasma levels of 30 cytokines were developed. Cross-validated estimates of area under the receiver operating characteristic curve (AUC) and log likelihood were used to assess prediction accuracy. Dose-only models predicted grade 3 RE with AUC values of 0.750 (D2cc) and 0.727 (gEUD). Combining clinical factors with D2cc increased the AUC to 0.779. Incorporating pretreatment cytokine measurements, modeled as direct associations with RE and as potential interactions with the dose-esophagitis association, produced AUC values of 0.758 and 0.773, respectively. D2cc and gEUD correlated with grade 3 RE with odds ratios (ORs) of 1.094/Gy and 1.096/Gy, respectively. Female gender was associated with a higher risk of RE, with ORs of 1.09 and 1.112 in the D2cc and gEUD models, respectively. Older age was associated with decreased risk of RE, with ORs of 0.992/year and 0.991/year in the D2cc and gEUD models, respectively. Combining clinical with dosimetric factors but not pretreatment cytokine levels yielded improved prediction of grade 3 RE compared to prediction by dose alone. Such multifactorial modeling may prove useful in directing radiation treatment planning.
first_indexed 2024-12-11T07:30:06Z
format Article
id doaj.art-807aa9f845534e57980033eb1a73c236
institution Directory Open Access Journal
issn 1936-5233
1944-7124
language English
last_indexed 2024-12-11T07:30:06Z
publishDate 2018-02-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-807aa9f845534e57980033eb1a73c2362022-12-22T01:15:50ZengElsevierTranslational Oncology1936-52331944-71242018-02-0111110210810.1016/j.tranon.2017.11.005Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine LevelsPeter G. Hawkins0Philip S. Boonstra1Stephen T. Hobson2James A. Hayman3Randall K. Ten Haken4Martha M. Matuszak5Paul Stanton6Gregory P. Kalemkerian7Theodore S. Lawrence8Matthew J. Schipper9Feng-Ming (Spring) Kong10Shruti Jolly11Department of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Biostatistics, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Internal Medicine, Division of Medical Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaDepartment of Radiation Oncology, Indiana University, 535 Barnhill Drive, Indianapolis, IN 46202, United States of AmericaDepartment of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, United States of AmericaRadiation esophagitis (RE) is a common adverse event associated with radiotherapy for non–small cell lung cancer (NSCLC). While plasma cytokine levels have been correlated with other forms of radiation-induced toxicity, their association with RE has been less well studied. We analyzed data from 126 patients treated on 4 prospective clinical trials. Logistic regression models based on combinations of dosimetric factors [maximum dose to 2 cubic cm (D2cc) and generalized equivalent uniform dose (gEUD)], clinical variables, and pretreatment plasma levels of 30 cytokines were developed. Cross-validated estimates of area under the receiver operating characteristic curve (AUC) and log likelihood were used to assess prediction accuracy. Dose-only models predicted grade 3 RE with AUC values of 0.750 (D2cc) and 0.727 (gEUD). Combining clinical factors with D2cc increased the AUC to 0.779. Incorporating pretreatment cytokine measurements, modeled as direct associations with RE and as potential interactions with the dose-esophagitis association, produced AUC values of 0.758 and 0.773, respectively. D2cc and gEUD correlated with grade 3 RE with odds ratios (ORs) of 1.094/Gy and 1.096/Gy, respectively. Female gender was associated with a higher risk of RE, with ORs of 1.09 and 1.112 in the D2cc and gEUD models, respectively. Older age was associated with decreased risk of RE, with ORs of 0.992/year and 0.991/year in the D2cc and gEUD models, respectively. Combining clinical with dosimetric factors but not pretreatment cytokine levels yielded improved prediction of grade 3 RE compared to prediction by dose alone. Such multifactorial modeling may prove useful in directing radiation treatment planning.http://www.sciencedirect.com/science/article/pii/S1936523317303534
spellingShingle Peter G. Hawkins
Philip S. Boonstra
Stephen T. Hobson
James A. Hayman
Randall K. Ten Haken
Martha M. Matuszak
Paul Stanton
Gregory P. Kalemkerian
Theodore S. Lawrence
Matthew J. Schipper
Feng-Ming (Spring) Kong
Shruti Jolly
Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
Translational Oncology
title Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
title_full Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
title_fullStr Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
title_full_unstemmed Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
title_short Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels
title_sort prediction of radiation esophagitis in non small cell lung cancer using clinical factors dosimetric parameters and pretreatment cytokine levels
url http://www.sciencedirect.com/science/article/pii/S1936523317303534
work_keys_str_mv AT peterghawkins predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT philipsboonstra predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT stephenthobson predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT jamesahayman predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT randallktenhaken predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT marthammatuszak predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT paulstanton predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT gregorypkalemkerian predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT theodoreslawrence predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT matthewjschipper predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT fengmingspringkong predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels
AT shrutijolly predictionofradiationesophagitisinnonsmallcelllungcancerusingclinicalfactorsdosimetricparametersandpretreatmentcytokinelevels